Arena Pharmaceuticals, Inc. (ARNA) Stock Falls -2.32% This Week: Is It a Good Pick?

Tuesday, September 14, 2021 02:12 PM | InvestorsObserver Analysts

Mentioned in this article

Arena Pharmaceuticals, Inc. (ARNA) Stock Falls -2.32% This Week: Is It a Good Pick?

Arena Pharmaceuticals, Inc. (ARNA) stock is lower by -12.96% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ARNA stock a score of 35 out of a possible 100. That rank is mainly influenced by a short-term technical score of 13. ARNA's rank also includes a long-term technical score of 22. The fundamental score for ARNA is 70. In addition to the average rating from Wall Street analysts, ARNA stock has a mean target price of $97.43. This means analysts expect the stock to rise 66.60% over the next 12 months.

ARNA has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on ARNA!

See Full ARNA Report

What's Happening with ARNA Stock Today

Arena Pharmaceuticals, Inc. (ARNA) stock is down -1.33% while the S&P 500 is lower by -0.35% as of 2:09 PM on Tuesday, Sep 14. ARNA is lower by -$0.79 from the previous closing price of $59.27 on volume of 172,768 shares. Over the past year the S&P 500 has risen 31.61% while ARNA is lower by -12.96%. ARNA lost -$8.17 per share in the over the last 12 months. Click Here to get the full Stock Report for Arena Pharmaceuticals, Inc. stock.